Jeffrey S. Parkin

Array ( [id] => 6791599 [patent_doc_number] => 20030086943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain' [patent_app_type] => new [patent_app_number] => 10/179152 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12039 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086943.pdf [firstpage_image] =>[orig_patent_app_number] => 10179152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750254 [patent_doc_number] => 20030044774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Multiple epitope fusion protein' [patent_app_type] => new [patent_app_number] => 10/174652 [patent_app_country] => US [patent_app_date] => 2002-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12230 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044774.pdf [firstpage_image] =>[orig_patent_app_number] => 10174652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7619937 [patent_doc_number] => 06943246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => '3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 10/158314 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21581 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943246.pdf [firstpage_image] =>[orig_patent_app_number] => 10158314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760785 [patent_doc_number] => 20030124146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Recombinant Rhabdoviruses as live-viral vaccines' [patent_app_type] => new [patent_app_number] => 10/150165 [patent_app_country] => US [patent_app_date] => 2002-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23602 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124146.pdf [firstpage_image] =>[orig_patent_app_number] => 10150165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 916601 [patent_doc_number] => 07323183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Vaccine compositions including chitosan for intranasal administration and use thereof' [patent_app_type] => utility [patent_app_number] => 10/141312 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 5893 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323183.pdf [firstpage_image] =>[orig_patent_app_number] => 10141312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931031 [patent_doc_number] => 06979535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays' [patent_app_type] => utility [patent_app_number] => 10/133357 [patent_app_country] => US [patent_app_date] => 2002-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 5899 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979535.pdf [firstpage_image] =>[orig_patent_app_number] => 10133357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 846938 [patent_doc_number] => 07384637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Drug for AIDS treatment' [patent_app_type] => utility [patent_app_number] => 10/118017 [patent_app_country] => US [patent_app_date] => 2002-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3173 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384637.pdf [firstpage_image] =>[orig_patent_app_number] => 10118017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44454 [patent_doc_number] => 07777011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Prion-specific polyclonal antibodies' [patent_app_type] => utility [patent_app_number] => 10/116061 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11393 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777011.pdf [firstpage_image] =>[orig_patent_app_number] => 10116061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749891 [patent_doc_number] => 20030044411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Methods for inhibiting HIV-1 infection' [patent_app_type] => new [patent_app_number] => 10/116797 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26817 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044411.pdf [firstpage_image] =>[orig_patent_app_number] => 10116797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169832 [patent_doc_number] => 07662394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence' [patent_app_type] => utility [patent_app_number] => 10/500796 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31391 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662394.pdf [firstpage_image] =>[orig_patent_app_number] => 10500796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267005 [patent_doc_number] => 07566529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Method for the recovery of retroviral reverse transcriptase (RT) activity from a sample containing unprotected cellular polymerases' [patent_app_type] => utility [patent_app_number] => 10/472756 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5440 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566529.pdf [firstpage_image] =>[orig_patent_app_number] => 10472756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765215 [patent_doc_number] => 20030099613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Viral replicons and viruses dependent on inducing agents' [patent_app_type] => new [patent_app_number] => 10/097542 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9666 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099613.pdf [firstpage_image] =>[orig_patent_app_number] => 10097542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 765312 [patent_doc_number] => 07008622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-07 [patent_title] => 'Methods and compositions for impairing multiplication of HIV-1' [patent_app_type] => utility [patent_app_number] => 10/086208 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23504 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008622.pdf [firstpage_image] =>[orig_patent_app_number] => 10086208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175629 [patent_doc_number] => 20020155435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Detection of dengue virus' [patent_app_type] => new [patent_app_number] => 10/085944 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4272 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155435.pdf [firstpage_image] =>[orig_patent_app_number] => 10085944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110444 [patent_doc_number] => 20020172683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Application to the stimulation of CTL and vaccination in vivo; analysis of vaccinating composition in vitro' [patent_app_type] => new [patent_app_number] => 10/083678 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22253 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172683.pdf [firstpage_image] =>[orig_patent_app_number] => 10083678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817657 [patent_doc_number] => 20030068615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Polypeptides that bind HIV gp120 and related nucleic acids, antibodies, compositions, and methods of use' [patent_app_type] => new [patent_app_number] => 10/084813 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15488 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068615.pdf [firstpage_image] =>[orig_patent_app_number] => 10084813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860979 [patent_doc_number] => 20030091987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Materials and methods for detecting, preventing, and treating retroviral infection' [patent_app_type] => new [patent_app_number] => 10/080772 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12993 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091987.pdf [firstpage_image] =>[orig_patent_app_number] => 10080772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 922955 [patent_doc_number] => 07318927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 10/469256 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8291 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/318/07318927.pdf [firstpage_image] =>[orig_patent_app_number] => 10469256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536214 [patent_doc_number] => 20020193304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Anti-HIV agents' [patent_app_type] => new [patent_app_number] => 10/076421 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12017 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193304.pdf [firstpage_image] =>[orig_patent_app_number] => 10076421 [rel_patent_id] =>[rel_patent_doc_number] =>)